vs
Side-by-side financial comparison of Ceribell, Inc. (CBLL) and CIVISTA BANCSHARES, INC. (CIVB). Click either name above to swap in a different company.
CIVISTA BANCSHARES, INC. is the larger business by last-quarter revenue ($47.3M vs $24.8M, roughly 1.9× Ceribell, Inc.). CIVISTA BANCSHARES, INC. runs the higher net margin — 31.7% vs -54.6%, a 86.3% gap on every dollar of revenue.
Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.
Civista Bancshares, Inc. is a US-based bank holding company operating primarily across the Midwest region. It provides a full suite of personal and commercial banking services including deposit accounts, mortgage, consumer and commercial lending products, as well as wealth management solutions, serving retail consumers, small and medium-sized local businesses and community client segments.
CBLL vs CIVB — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $24.8M | $47.3M |
| Net Profit | $-13.5M | $15.0M |
| Gross Margin | 87.3% | — |
| Operating Margin | -58.9% | — |
| Net Margin | -54.6% | 31.7% |
| Revenue YoY | — | — |
| Net Profit YoY | — | 47.4% |
| EPS (diluted) | $-0.35 | $0.72 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $47.3M | ||
| Q4 25 | $24.8M | $46.3M | ||
| Q3 25 | $22.6M | $44.2M | ||
| Q2 25 | $21.2M | $41.4M | ||
| Q1 25 | $20.5M | $40.6M | ||
| Q4 24 | — | $40.4M | ||
| Q3 24 | $17.2M | $39.3M | ||
| Q2 24 | — | $38.1M |
| Q1 26 | — | $15.0M | ||
| Q4 25 | $-13.5M | — | ||
| Q3 25 | $-13.5M | $12.8M | ||
| Q2 25 | $-13.6M | $11.0M | ||
| Q1 25 | $-12.8M | $10.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-10.4M | $8.4M | ||
| Q2 24 | — | $7.1M |
| Q1 26 | — | — | ||
| Q4 25 | 87.3% | — | ||
| Q3 25 | 88.3% | — | ||
| Q2 25 | 88.1% | — | ||
| Q1 25 | 87.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 87.3% | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | -58.9% | 31.8% | ||
| Q3 25 | -64.8% | 35.4% | ||
| Q2 25 | -70.5% | 31.1% | ||
| Q1 25 | -69.3% | 29.4% | ||
| Q4 24 | — | 28.2% | ||
| Q3 24 | -57.8% | 25.2% | ||
| Q2 24 | — | 21.2% |
| Q1 26 | — | 31.7% | ||
| Q4 25 | -54.6% | — | ||
| Q3 25 | -59.6% | 28.9% | ||
| Q2 25 | -64.4% | 26.6% | ||
| Q1 25 | -62.4% | 25.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | -60.6% | 21.3% | ||
| Q2 24 | — | 18.5% |
| Q1 26 | — | $0.72 | ||
| Q4 25 | $-0.35 | $0.59 | ||
| Q3 25 | $-0.37 | $0.68 | ||
| Q2 25 | $-0.38 | $0.71 | ||
| Q1 25 | $-0.36 | $0.66 | ||
| Q4 24 | — | $0.62 | ||
| Q3 24 | $-1.85 | $0.53 | ||
| Q2 24 | — | $0.45 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $159.3M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $155.3M | $553.9M |
| Total Assets | $195.8M | $4.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $159.3M | — | ||
| Q3 25 | $168.5M | — | ||
| Q2 25 | $177.4M | — | ||
| Q1 25 | $182.7M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $14.1M | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $553.9M | ||
| Q4 25 | $155.3M | $543.5M | ||
| Q3 25 | $164.1M | $499.0M | ||
| Q2 25 | $172.2M | $404.1M | ||
| Q1 25 | $180.9M | $397.4M | ||
| Q4 24 | — | $388.5M | ||
| Q3 24 | $-136.0M | $394.4M | ||
| Q2 24 | — | $373.8M |
| Q1 26 | — | $4.3B | ||
| Q4 25 | $195.8M | $4.3B | ||
| Q3 25 | $199.5M | $4.1B | ||
| Q2 25 | $207.7M | $4.2B | ||
| Q1 25 | $213.5M | $4.1B | ||
| Q4 24 | — | $4.1B | ||
| Q3 24 | $47.1M | $4.1B | ||
| Q2 24 | — | $4.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.8M | — |
| Free Cash FlowOCF − Capex | $-11.0M | — |
| FCF MarginFCF / Revenue | -44.2% | — |
| Capex IntensityCapex / Revenue | 0.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-41.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-10.8M | $43.3M | ||
| Q3 25 | $-11.1M | $19.0M | ||
| Q2 25 | $-7.5M | $11.1M | ||
| Q1 25 | $-11.4M | $3.6M | ||
| Q4 24 | — | $48.2M | ||
| Q3 24 | — | $12.9M | ||
| Q2 24 | — | $12.2M |
| Q1 26 | — | — | ||
| Q4 25 | $-11.0M | $42.1M | ||
| Q3 25 | $-11.5M | — | ||
| Q2 25 | $-7.6M | — | ||
| Q1 25 | $-11.6M | $3.5M | ||
| Q4 24 | — | $44.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | -44.2% | 90.9% | ||
| Q3 25 | -50.8% | — | ||
| Q2 25 | -35.9% | — | ||
| Q1 25 | -56.4% | 8.5% | ||
| Q4 24 | — | 109.1% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.7% | 2.5% | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.7% | 0.4% | ||
| Q4 24 | — | 10.4% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 1.49× | ||
| Q2 25 | — | 1.01× | ||
| Q1 25 | — | 0.36× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.54× | ||
| Q2 24 | — | 1.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
CIVB
| Net Interest Income | $37.8M | 80% |
| Noninterest Income | $9.4M | 20% |
